ADT has not disclosed specific plans for AI technology, but this comes at a time when concerns about corporate surveillance ...

PEACE-2 finds adding cabazitaxel to ADT plus radiotherapy fails to improve survival in high-risk localized prostate cancer, while increasing severe toxicities and deaths.

ADT Inc. (NYSE: ADT) will release Q4 earnings on March 2. Analysts expect 22 cents per share, up from 20 cents last year. Annual dividend yield is 2.71%.

Researchers sought to determine if adding cabazitaxel to a regimen of androgen deprivation therapy plus radiotherapy improved clinical progression free survival in very high risk prostate cancer.

Discover the top 4 undervalued Diversified Consumer Services stocks for Wednesday, February 25 based on AAII’s Stock Grades.

ADTechnology says on the 23rd it pushes a strategic technology partnership with Germany's Fraunhofer Institute for Integrated Circuits to jointly develop 4-nanometer (nm, one hundred-millionth of a ...

By Aditya Soni and Jaspreet Singh Feb 12 (Reuters) - Finding security camera footage in the high-profile abduction of Nancy Guthrie may have been delayed because it probably was stored as unorganized ...

Check your weather forecast for clear skies, so you don't miss the spectacular astronomical events occurring throughout the ...

​According to the most recent SafeWise Package Theft Report, porch piracy is the most common crime in the U.S. The three states most at risk of porch pirates include California, New York, and Texas, ...

Cardio-oncology clinics manage diverse therapy-associated phenotypes including early-onset heart failure, ...

Over 200 defence personnel, scientists, and industry participants from Australia, the United Kingdom, and the United States came together on ...